1. Fabrication of decellularized skeletal muscle sheet (DSMS).
Sheet-like substrates DSMS were fabricated from decellularized skeletal muscle. The decellularization technique was a modified version of the technique proposed by Urciuolo et al. [33]. The commercially available chicken breast meat was purchased and shaped using a surgical knife, subsequently frozen at − 30°C for overnight (O/N). Then, the frozen meat was sliced (1 mm thickness) longitudinally to the orientation of the muscle fibers using an electric meat slicer (RSL-220, Remacom, Mishima, Shizuoka, Japan). The slices were then washed with sterile ultra-pure water containing 1% penicillin-streptomycin (P/S, Thermo Fisher Scientific, Waltham, MA) and 250 µg/mL amphotericin B (AmB, Thermo) for 1 h.
The solution used in all decellularization processes was four times the volumes of the initial weight of the meat slices and was subjected to reciprocal shaking (NR-3, TAITEC, Saitama, Japan) at 100 rotations per minute at room temperature. The slices were then washed with sterile 1% sodium dodecyl sulfate (SDS) solution for 50 h to remove cellular components, during which the 1% SDS solution was changed four times. Next, the remaining SDS in the sheets was removed by washing with sterile 0.01N NaOH solution for 15 min, followed by washing five times with sterile 50% ethanol for 1 h each. The sheets were washed twice for 10 min with a sterile storage solution (PBS, 1% P/S, 250 µg/mL AmB). Finally, the sheets were trimmed into 2 cm square using surgical knives, and DSMSs were prepared. The prepared DSMSs were stored at 4°C in a sterile storage solution for short-term storage and at − 30°C in a sterile antifreeze storage solution (PBS, 65% v/v glycerol, 1% P/S, 250µg/mL AmB) for long-term storage. DSMS stored in antifreeze solution was brought back to room temperature and was washed twice with a storage solution for 10 min for further use.
In order to confirm the progress of decellularization, the time course of change in the amount of protein eluted in the decellularization solution and in the protein component remaining in the skeletal muscle sheets was measured. The amount of protein eluted in the decellularization solution was determined by collecting a portion of the solution 30 min after the decellularization solution was changed. Protein quantification was performed using a BCA protein quantification kit (Pierce BCA Protein Assay Kit, Thermo). The amount of eluted protein was calculated as the amount of eluted protein per minute. To determine changes in residual protein components in the skeletal muscle sheets, a portion of the sheets was collected during the decellularization process and homogenized in SDS sampling buffer (62.5 mM Tris-HCl (pH 6.8), 2% (w/v) SDS, 10% glycerol, and 0.01% (w/v) bromophenol blue 42 mM dithiothreitol). The extracted proteins were subjected to BCA protein quantification, and the equal amounts of proteins were subjected to electrophoresis by SDS-PAGE. The gels were then stained with Coomassie Brilliant Blue stain to visualize the protein bands and imaged with a gel imaging system.
DSMS was attached to the polydimethylsiloxane (PDMS) chamber (Strex, Osaka, Japan) prior to use for DSMS stretching tests and cell culture. DSMS was placed in a PDMS chamber in PBS, with the ECM in the DSMS aligned with the stretching direction of the chamber. Then, PBS was removed, and DSMS was semi-dried for 30 min in a 37°C humidified CO2 incubator. After that, PBS was added to rewet DSMS. This step allowed DSMS to stick tightly to the chamber even during cell culture. DSMS's characteristic to stick to the chamber enabled the same culture operations as conventional.
Stretching tests were performed to confirm the properties of DSMS. Stretching was performed uniaxially and aligned with the orientation of the DSMS.
Manual stretching was applied to confirm that the DSMS would stretch to the same degree when stretched through the chamber. The chamber with DSMS was set on a manual stretching tool (100 − 10, Strex) and stretched at different ratios, and the length change of the DSMS was measured. Automatic stretching was applied to observe the tolerance of the DSMS to repetitive stretching. The chamber with DSMS was set in the automatic stretching system (1400-10-R5, Strex) and repeatedly stretched at 1 Hz for 3 hours at a 20% stretching ratio.
2. Cell culture.
Mouse skeletal myoblasts (C2C12) were growth cultured on a plastic dish in a growth medium (GM, Dulbecco's modified Eagle's medium (DMEM) (10313021, Thermo) supplemented with 20% fetal bovine serum (26140-079, Thermo) and 1% P/S (Thermo)). Growth C2C12 was passed before reaching 80% confluence and used within 10 passages to prevent loss of myogenic differentiation ability. Differentiation of C2C12 into myotubes was inducted with differentiation medium (DM, DMEM supplemented with 2% donor horse serum (2921149, MP Biomedicals, Tokyo, Japan) and 1% P/S). Cells were cultured at humidified 37°C under 5% CO2, with the medium replaced every other day.
3. Myoblast adhesion and myotube formation on DSMS or plastic dish.
The C2C12 cells prepared in plastic plates were detached using 0.25% trypsin-EDTA, then suspended in GM, and seeded at 4 × 104 cells/cm2 on DSMS attached to the chamber or on plastic dishes. Then, C2C12 was allowed to grow for two days, and differentiation was promoted by replacing the medium with DM.
4. Fluorescent microscopic observation.
Fluorescent staining was performed to observe the state of myoblast adhesion and myotube formation. Myocytes on DSMS were fixed with 4% paraformaldehyde for 25 min, washed three times with PBS for 10 min each, and then permeabilized with 0.3% Triton X-100 in PBS for 10 min. Next, the tissues were washed three times with PBS for 10 min each and blocked with a blocking solution (1% gelatin in PBS) for 30 min at room temperature. The tissues were then incubated with primary antibody (rabbit anti-COL IV antibody, AB756P, Millipore, Billerica, MA, USA) at 4°C overnight. They were again incubated with secondary antibody Alexa Fluor 546 Goat Anti-Rabbit IgG (H + L; Thermo) for 1 h at room temperature and later at 4°C O/N with Hoechst 33342 and Alexa Fluor 488 conjugated phalloidin (Thermo). For better microscopic observability, myocytes on DSMSs were incubated in a tissue clearing reagent ScaleS4 [40% (w/v) D-sorbitol, 10% (w/v) glycerol, 4 M urea, 15% DMSO in H2O] for 30 min prior to microscopic observation [34].
Calcein staining was performed to observe myotube survival in long-term culture on DSMS and plastic dishes. After 6 and 12 days of differentiation, living myotubes were washed with FluoroBrite DMEM (Thermo) and incubated with FluoroBrite DMEM containing 10 µg/mL of calcein-AM (Dojindo Laboratories, Kumamoto, Japan) for 60 min at 37°C. The cells were then washed with FluoroBrite DMEM and observed under the fluorescence microscope.
A BZ-X700 (KEYENCE, Osaka, Japan) was used for microscopic observation, and multifocal images were acquired using the z-stack function. The images were analyzed using ImageJ software (National Institutes of Health, Bethesda, MD, USA) [35].
5. Semi-quantitative reverse transcriptional PCR.
The mRNA expression levels of myocytes on DSMS and plastic dishes were measured on day 1 of the growth phase and days 0, 3, 6, and 12 of the differentiation phase. The mRNA expression levels were determined by semi-quantitative reverse transcriptional (RT) -PCR. As per the manufacturer's instructions, total RNA was extracted from myocytes on DSMS and plastic dish using Qiazol and RNeasy mini kit (74104, Qiagen, Hilden, Germany). Possible contamination of genomic DNA was degraded using DNase I (Takara Bio Inc., Shiga, Japan) treatment for 15 min at room temperature. 1000 ng of total RNA was used for reverse transcription primed with Oligo(dT) using an AffinityScript QPCR cDNA Synthesis Kit (600559, Agilent Technologies, Texas, USA). Then, RT-PCR was performed (EmeraldAmp PCR Kit, Takara). The primer sequences used in this study are listed in Table 1.
PCR products were electrophoresed using a 2% agarose gel and stained by SYBR Gold (Thermo).
Gels were then detected with a UV gel imager (Amersham Imager 600, GE Healthcare Bioscience, Piscataway, NJ, USA), and band intensities were quantified using ImageJ densitometry.
The quantified mRNA expression levels were corrected for GAPDH mRNA levels and normalized to the levels of myocytes on DSMS day 1 of the growth phase.
Table 1
Primer sequences used in semi-quantitative RT PCR.
Gene | F-Primer | R-Primer |
Myf5 | 5'-TGTATCCCCTCACCAGAGGAT-3' | 5'-GGCTGTAATAGTTCTCCACCTGTT-3' |
MyoD | 5'-AGTGAATGAGGCCTTCGAGA-3' | 5'-CTGGGTTCCCTGTTCTGTGT-3' |
Myogenin | 5'-ACCAGGAGCCCCACTTCTAT-3' | 5'-ACGATGGACGTAAGGGAGTG-3' |
Desmin | 5'-TCTCCCGTGTTCCCT-3' | 5'-ATACGAGCTAGAGTGGCA-3' |
MHC embryonic | 5'-TCCGACAACGCCTACCAGTT-3' | 5'-CCCGGATTCTCCGGTGAT-3' |
MHC neonatal | 5'-CAGGAGCAGGAATGATGCTCTGAG-3' | 5'-AGTTCCTCAAACTTTCAGCAGCCAA-3' |
GAPDH | 5'-ACTCCACTCACGGCAAATTC-3' | 5'-CCTTCCACAATGCCAAAGTT-3' |
6. Statistical analysis.
Statistical analysis was performed using a t-test for independent samples with unequal variance using the Prism 9 software (GraphPad Software, LaJolla, CA, USA).